Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.74 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.74 |
| ▸ | MAPT | P10636 | 7/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.63 |
| ▸ | RXRA | P19793 | 5/20 | 0.63 |
| ▸ | RARA | P10276 | 4/20 | 0.63 |
| ▸ | RARB | P10826 | 4/20 | 0.63 |
| ▸ | RARG | P13631 | 4/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.63 |
| ▸ | APP | P05067 | 4/20 | 0.63 |
| ▸ | SNCA | P37840 | 4/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.63 |
| ▸ | RXRB | P28702 | 2/20 | 0.63 |
| ▸ | RXRG | P48443 | 2/20 | 0.63 |
| ▸ | RORC | P51449 | 2/20 | 0.63 |
| ▸ | HTR2B | P41595 | 2/20 | 0.63 |
| ▸ | BLM | P54132 | 2/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.63 |
| ▸ | DRD3 | P35462 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2006702 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL1895263 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL2008326 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL1695153 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL3422972 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL4399478 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL2011547 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL2005744 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL2005804 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA | |
| SCHEMBL2008700 | 1.00 | ALDH1A1 (0.74) | ALDH1A1ADORA3MAPTCYP3A4RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 26690 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4743051-A1 | 3-HYDROXYPROPYLESTERS AS SOLUBILITY ENHANCERS FOR LIPOPHILIC INGREDIENTS | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| WO-2026101808-A1 | TOPICAL NEUROCOSMETIC COMPOSITIONS AND METHODS FOR MODULATING SKIN-NEURON INTERACTIONS | III INTERNATIONAL HOLDINGS, LLC (US) | 2026-05-15 | — | — | WO | claimed |
| US-20260131089-A1 | DRUG DELIVERY DEVICES AND METHODS FOR ADMINISTERING SUBSTANCES TO A BODY CAVITY BY HETEROGENOUS AEROSOLIZATION FOR TREATMENT OF BINGE-EATING DISORDERS AND/OR OBESITY | APTARGROUP, INC. (US) | 2026-05-14 | — | — | US | claimed |
| US-20260115155-A1 | STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN | CHORDA PHARMA INC (US) | 2026-04-30 | — | — | US | claimed |
| WO-2026087103-A1 | COMBINATION OF RETINOL, ALKYLAMIDOTHIAZOLES AND FLAVONOIDS FOR IMPROVING ACTIVE SUBSTANCE STABILIZATION | BEIERSDORF AG (DE) | 2026-04-30 | — | — | WO | claimed |
| EP-4351513-B1 | SKIN CARE COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2026-04-15 | — | — | EP | claimed |
| EP-4722158-A1 | HOLLOW MESOPOROUS SILICA ROD, METHOD FOR PREPARING SAME, AND METHOD FOR SUPPORTING ACTIVE SUBSTANCE | BN Co., Ltd. (KR) | 2026-04-08 | — | — | EP | claimed |
| EP-4719336-A1 | SKIN ANTI-AGEING COMPOSITION | LYMA Life Ltd. (GB) | 2026-04-08 | — | — | EP | claimed |
| EP-4712940-A1 | COMPOSITION FOR CARING FOR THE KERATIN MATERIALS | L'OREAL (FR) | 2026-03-25 | — | — | EP | claimed |
| EP-0415766-A2 | Use of retinoids for reversing glucocorticoid-induced skin atrophy | ORTHO PHARMACEUTICAL CORPORATION (US) | 1991-03-06 | — | — | EP | claimed |
| WO-1990014836-A1 | METHODS OF IMPROVED SKIN CARE AND THE TREATMENT OF DERMATOLOGICAL CONDITIONS | SCHAEFFER HANS A (US) | 1990-12-13 | — | — | WO | claimed |
| WO-1990012083-A1 | HIGH CALCIUM CHEMICALLY DEFINED CULTURE MEDIUM | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1990-10-18 | — | — | WO | claimed |
| EP-0391033-A2 | Retinal, derivatives and their therapeutic use | Yu, Ruey J., Dr. (US) | 1990-10-10 | — | — | EP | claimed |
| EP-0358528-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1990-03-14 | — | — | EP | claimed |
| US-4888363-A | FOR APPLYING TO SKIN | AVON PRODUCTS, INC. (US) | 1989-12-19 | — | — | US | claimed |
| EP-0334486-A2 | Hair care compositions | BEECHAM GROUP PLC (GB) | 1989-09-27 | — | — | EP | claimed |
| EP-0330496-A2 | Skin treatment composition | BEECHAM GROUP PLC (GB) | 1989-08-30 | — | — | EP | claimed |
| US-4839164-A | ENHANCED PENETRATION OF SKIN | ESTEE LAUDER, INC. (US) | 1989-06-13 | — | — | US | claimed |
| EP-0255364-A2 | Anhydrous cosmetic preparation | AVON PRODUCTS, INC. (US) | 1988-02-03 | — | — | EP | claimed |